On Monday, Altimmune Inc (NASDAQ: ALT) opened higher 0.74% from the last session, before settling in for the closing price of $6.74. Price fluctuations for ALT have ranged from $2.32 to $14.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 115.21% over the last five years. Company’s average yearly earnings per share was noted 16.61% at the time writing. With a float of $70.48 million, this company’s outstanding shares have now reached $70.68 million.
The firm has a total of 59 workers. Let’s measure their productivity. In terms of profitability, gross margin is -4899.02%, operating margin of -23785.57%, and the pretax margin is -24778.97%.
Altimmune Inc (ALT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Altimmune Inc is 0.83%, while institutional ownership is 59.63%. The most recent insider transaction that took place on Aug 19 ’24, was worth 110,547. In this transaction Director of this company sold 16,011 shares at a rate of $6.90, taking the stock ownership to the 41,958 shares.
Altimmune Inc (ALT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 16.61% per share during the next fiscal year.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Check out the current performance indicators for Altimmune Inc (ALT). In the past quarter, the stock posted a quick ratio of 11.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1177.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Analysing the last 5-days average volume posted by the [Altimmune Inc, ALT], we can find that recorded value of 2.35 million was lower than the volume posted last year of 3.78 million. As of the previous 9 days, the stock’s Stochastic %D was 23.98%. Additionally, its Average True Range was 0.44.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 47.12%, which indicates a significant increase from 30.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.79% in the past 14 days, which was lower than the 78.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.76, while its 200-day Moving Average is $7.70. Now, the first resistance to watch is $6.93. This is followed by the second major resistance level at $7.08. The third major resistance level sits at $7.32. If the price goes on to break the first support level at $6.55, it is likely to go to the next support level at $6.31. Should the price break the second support level, the third support level stands at $6.16.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are currently 71,071K shares outstanding in the company with a market cap of 482.57 million. Presently, the company’s annual sales total 430 K according to its annual income of -88,450 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -24,640 K.
